Oct 22, 2022
On March 13, 2021, the European Medicines Agency issued an announcement. Based on two large “French and Nordic” studies, the EMA’s safety committee (PRAC) reviewed the risk of myocarditis and pericarditis after receiving COVID-19 vaccines produced by Pfizer and Moderna, and reached the following conclusion:
Overall, the outcome of the review confirms the risk of myocarditis and pericarditis, which is already reflected in the product information for these two vaccines, and provides further details on these two conditions.